Načítá se...
PCSK9 and Atherosclerosis - Lipids and Beyond
Even though it is only a little over a decade from the discovery of proprotein convertase subtilisin/kexin type 9 (PCSK9) as a plasma protein that associates with both high and low cholesterol syndromes, a rich body of knowledge has developed, and drugs inhibiting this target have been approved in m...
Uloženo v:
| Vydáno v: | J Atheroscler Thromb |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Japan Atherosclerosis Society
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5429160/ https://ncbi.nlm.nih.gov/pubmed/28302950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|